CITADEL ADVISORS LLC historic quarter change: USA Bonds: Other Debt, Reduced
In other debt filed by principal amount (debentures, bonds) (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 884 positions, added to 1,270, reduced 1,104 and sold out of 996.
- Q3 2017: Stock NOVELLUS SYS INC; Country of operation —; Class Bond; Principal before $112,034,000.
- Q3 2017: Stock NUVASIVE INC; Country of operation —; Class Bond; Principal before $77,363,000.
- Q3 2017: Stock INTERCEPT PHARMACEUTICALS IN; Country of operation —; Class Bond; Principal before $48,100,000.
- Q3 2017: Stock ACCURAY INC; Country of operation —; Class Bond; Principal before $35,071,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Principal before | Principal after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2017 | NOVELLUS SYS INC
CUSIP 670008AD3 | — | Bond | $112,034,000 | $106,508,000 | -5,526,000 | $469,668 | $585,680 | +$116,012 | 2017-11-09 |
|---|
| Q3 2017 | NUVASIVE INC
CUSIP 670704AG0 | — | Bond | $77,363,000 | $59,863,000 | -17,500,000 | $107,049 | $68,373 | -$38,676 | 2017-11-09 |
|---|
| Q3 2017 | INTERCEPT PHARMACEUTICALS IN
CUSIP 45845PAA6 | — | Bond | $48,100,000 | $17,800,000 | -30,300,000 | $46,963 | $13,845 | -$33,118 | 2017-11-09 |
|---|
| Q3 2017 | ACCURAY INC
CUSIP 004397AF2 | — | Bond | $35,071,000 | $5,855,000 | -29,216,000 | $38,056 | $5,986 | -$32,070 | 2017-11-09 |
|---|
| Q3 2017 | PRICELINE GRP INC
CUSIP 741503AQ9 | — | Bond | $94,530,000 | $83,030,000 | -11,500,000 | $186,573 | $160,549 | -$26,024 | 2017-11-09 |
|---|
| Q3 2017 | VEECO INSTRS INC DEL
CUSIP 922417AD2 | — | Bond | $58,000,000 | $36,000,000 | -22,000,000 | $59,331 | $34,502 | -$24,829 | 2017-11-09 |
|---|
| Q3 2017 | CTRIP COM INTL LTD
CUSIP 22943FAD2 | — | Bond | $62,659,000 | $47,159,000 | -15,500,000 | $88,621 | $65,231 | -$23,390 | 2017-11-09 |
|---|
| Q3 2017 | VERISIGN INC
CUSIP 92343EAD4 | — | Bond | $175,627,000 | $160,627,000 | -15,000,000 | $478,587 | $500,287 | +$21,700 | 2017-11-09 |
|---|
| Q3 2017 | MEDICINES CO
CUSIP 584688AG0 | — | Bond | $45,000,000 | $25,000,000 | -20,000,000 | $47,190 | $26,290 | -$20,900 | 2017-11-09 |
|---|
| Q3 2017 | MICRON TECHNOLOGY INC
CUSIP 595112AU7 | — | Bond | $20,438,000 | $19,930,000 | -508,000 | $55,700 | $71,543 | +$15,843 | 2017-11-09 |
|---|
| Q3 2017 | PDC ENERGY INC
CUSIP 69327RAD3 | — | Bond | $35,000,000 | $19,000,000 | -16,000,000 | $31,822 | $18,560 | -$13,262 | 2017-11-09 |
|---|
| Q3 2017 | SILVER STD RES INC
CUSIP 82823LAC0 | — | Bond | $45,031,000 | $32,031,000 | -13,000,000 | $43,835 | $32,130 | -$11,705 | 2017-11-09 |
|---|
| Q3 2017 | SALESFORCE COM INC
CUSIP 79466LAD6 | — | Bond | $30,178,000 | $20,178,000 | -10,000,000 | $39,981 | $28,359 | -$11,622 | 2017-11-09 |
|---|
| Q3 2017 | CONVERGYS CORP
CUSIP 212485AE6 | — | Bond | $17,549,000 | $11,549,000 | -6,000,000 | $38,820 | $27,500 | -$11,320 | 2017-11-09 |
|---|
| Q3 2017 | NATIONAL HEALTH INVS INC
CUSIP 63633DAE4 | — | Bond | $38,349,000 | $31,341,000 | -7,008,000 | $44,779 | $36,186 | -$8,593 | 2017-11-09 |
|---|
| Q3 2017 | ENVESTNET INC
CUSIP 29404KAA4 | — | Bond | $34,260,000 | $25,160,000 | -9,100,000 | $33,646 | $26,438 | -$7,208 | 2017-11-09 |
|---|
| Q3 2017 | TESLA INC
CUSIP 88160RAD3 | — | Bond | $20,000,000 | $15,000,000 | -5,000,000 | $25,172 | $18,441 | -$6,731 | 2017-11-09 |
|---|
| Q3 2017 | VITAMIN SHOPPE INC
CUSIP 92849EAB7 | — | Bond | $29,500,000 | $23,200,000 | -6,300,000 | $23,304 | $17,261 | -$6,043 | 2017-11-09 |
|---|
| Q3 2017 | PTC THERAPEUTICS INC
CUSIP 69366JAB7 | — | Bond | $17,350,000 | $10,000,000 | -7,350,000 | $13,603 | $8,089 | -$5,514 | 2017-11-09 |
|---|
| Q3 2017 | YANDEX NV
CUSIP 98474TAB3 | — | Bond | $15,000,000 | $9,200,000 | -5,800,000 | $14,572 | $9,173 | -$5,399 | 2017-11-09 |
|---|
| Q3 2017 | VERINT SYS INC
CUSIP 92343XAA8 | — | Bond | $9,000,000 | $3,500,000 | -5,500,000 | $8,831 | $3,433 | -$5,398 | 2017-11-09 |
|---|
| Q3 2017 | ALLSCRIPTS HEALTHCARE SOLUTN
CUSIP 01988PAD0 | — | Bond | $7,500,000 | $3,000,000 | -4,500,000 | $7,617 | $3,187 | -$4,430 | 2017-11-09 |
|---|
| Q3 2017 | PROOFPOINT INC
CUSIP 743424AB9 | — | Bond | $107,776,000 | $105,276,000 | -2,500,000 | $239,625 | $235,379 | -$4,246 | 2017-11-09 |
|---|
| Q3 2017 | LIBERTY MEDIA CORP DELAWARE
CUSIP 531229AB8 | — | Bond | $76,100,000 | $71,100,000 | -5,000,000 | $90,370 | $86,165 | -$4,205 | 2017-11-09 |
|---|
| Q3 2017 | VECTOR GROUP LTD
CUSIP 92240MAY4 | — | Bond | $33,000,000 | $30,000,000 | -3,000,000 | $48,363 | $44,177 | -$4,186 | 2017-11-09 |
|---|
| Q3 2017 | TESLA INC
CUSIP 88160RAB7 | — | Bond | $22,500,000 | $20,000,000 | -2,500,000 | $25,758 | $21,974 | -$3,784 | 2017-11-09 |
|---|
| Q3 2017 | REPLIGEN CORP
CUSIP 759916AA7 | — | Bond | $12,103,000 | $10,103,000 | -2,000,000 | $17,388 | $13,644 | -$3,744 | 2017-11-09 |
|---|
| Q3 2017 | FIREEYE INC
CUSIP 31816QAD3 | — | Bond | $52,908,000 | $47,908,000 | -5,000,000 | $48,258 | $44,583 | -$3,675 | 2017-11-09 |
|---|
| Q3 2017 | AMTRUST FINL SVCS INC
CUSIP 032359AG6 | — | Bond | $16,650,000 | $12,650,000 | -4,000,000 | $12,489 | $9,365 | -$3,124 | 2017-11-09 |
|---|
| Q3 2017 | QUIDEL CORP
CUSIP 74838JAA9 | — | Bond | $28,100,000 | $22,600,000 | -5,500,000 | $31,238 | $34,257 | +$3,019 | 2017-11-09 |
|---|
| Q3 2017 | INVACARE CORP
CUSIP 461203AF8 | — | Bond | $31,500,000 | $26,000,000 | -5,500,000 | $33,929 | $31,124 | -$2,805 | 2017-11-09 |
|---|
| Q3 2017 | KEYW HLDG CORP
CUSIP 493723AA8 | — | Bond | $33,855,000 | $32,355,000 | -1,500,000 | $32,738 | $30,282 | -$2,456 | 2017-11-09 |
|---|
| Q3 2017 | WRIGHT MED GROUP INC
CUSIP 98235TAE7 | — | Bond | $33,500,000 | $32,500,000 | -1,000,000 | $37,343 | $35,164 | -$2,179 | 2017-11-09 |
|---|
| Q3 2017 | PORTFOLIO RECOVERY ASSOCS IN
CUSIP 73640QAB1 | — | Bond | $5,316,000 | $3,316,000 | -2,000,000 | $5,076 | $3,050 | -$2,026 | 2017-11-09 |
|---|
| Q3 2017 | SHIP FINANCE INTERNATIONAL L
CUSIP G81075AE6 | — | Bond | $9,444,000 | $7,444,000 | -2,000,000 | $10,152 | $8,180 | -$1,972 | 2017-11-09 |
|---|
| Q3 2017 | GOGO INC
CUSIP 38046CAB5 | — | Bond | $35,260,000 | $33,360,000 | -1,900,000 | $32,100 | $30,680 | -$1,420 | 2017-11-09 |
|---|
| Q3 2017 | NEVRO CORP
CUSIP 64157FAA1 | — | Bond | $33,400,000 | $31,400,000 | -2,000,000 | $35,855 | $37,254 | +$1,399 | 2017-11-09 |
|---|
| Q3 2017 | VECTOR GROUP LTD
CUSIP 92240MBC1 | — | Bond | $27,845,000 | $26,845,000 | -1,000,000 | $32,018 | $30,714 | -$1,304 | 2017-11-09 |
|---|
| Q3 2017 | SHIP FINANCE INTERNATIONAL L
CUSIP G81075AF3 | — | Bond | $6,500,000 | $5,000,000 | -1,500,000 | $6,277 | $5,253 | -$1,024 | 2017-11-09 |
|---|
| Q3 2017 | AEGERION PHARMACEUTICALS INC
CUSIP 00767EAB8 | — | Bond | $5,000,000 | $4,000,000 | -1,000,000 | $4,009 | $3,228 | -$781 | 2017-11-09 |
|---|
| Q3 2017 | INOTEK PHARMACEUTICALS CORP
CUSIP 45780VAB8 | — | Bond | $8,500,000 | $6,000,000 | -2,500,000 | $5,143 | $4,395 | -$748 | 2017-11-09 |
|---|
| Q3 2017 | COBALT INTL ENERGY INC
CUSIP 19075FAA4 | — | Bond | $11,000,000 | $9,000,000 | -2,000,000 | $2,702 | $2,144 | -$558 | 2017-11-09 |
|---|
| Q3 2017 | NOVAVAX INC
CUSIP 670002AB0 | — | Bond | $42,410,000 | $38,710,000 | -3,700,000 | $18,545 | $18,095 | -$450 | 2017-11-09 |
|---|
| Q3 2017 | WABASH NATL CORP
CUSIP 929566AH0 | — | Bond | $7,807,000 | $7,495,000 | -312,000 | $14,960 | $14,774 | -$186 | 2017-11-09 |
|---|
| Q3 2017 | AMAG PHARMACEUTICALS INC
CUSIP 00163UAD8 | — | Bond | $32,500,000 | $32,000,000 | -500,000 | $31,295 | $31,163 | -$132 | 2017-11-09 |
|---|